Catalyst

Slingshot members are tracking this event:

Heron (HRTX) Files New Drug Application with FDA in 2H 2018 for HTX-011 in Post-Operative Pain

Source Link:
https://herontherapeutics.gcs-web.com/news-releases/news-release-details/heron-therapeutics-announces-financial-results-three-and-twelve

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
HRTX
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Jun 21, 2018
Occurred Source:
https://herontherapeutics.gcs-web.com/news-releases/news-release-details/htx-011-postoperative-pain-management-receives-breakthrough
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords New Drug Application, Fda, Nda, Htx-011, Post-operative Pain
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.